Advertisement

Topics

Advanced BioScience Laboratories, Inc. (ABL) and AlphaCore Pharma Company Profile

12:13 EST 16th December 2018 | BioPortfolio


News Articles [1449 Associated News Articles listed on BioPortfolio]

Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to ...

Cyclenium Pharma Inc.Helmut Thomas, Ph.D., DABT, +1-819-571-4296President, CEO & CSOhthomas@cyclenium.comorHaplogen Bioscience GmbHGeorg Casari, Ph.D., +43-1-9165522Chief Exec...

Aytu BioScience, Inc.: Aytu BioScience Announces 7 Presentations of Clinical Findings for its Proprietary MiOXSYS(R) System at the 34th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE)

- Multi-Center, Global Study Demonstrates that MiOXSYS Provides an Accurate Measure of Seminal Oxidative Stress that can be Standardized Globally Within Clinical Andrology and IVF Laboratories - Pr...

IDEXX Laboratories Inc Q2 Earnings Rise

WASHINGTON (dpa-AFX) - IDEXX Laboratories Inc (IDXX) released earnings for its second quarter that advanced from last year.The company's profit came in at $108.68 million, or $1.23 per share. This...

#news #biotech Arix Bioscience acquires 11% stake in Phamaxis Ltd.

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Arix Bioscience acquires 11% stake in Phamaxis Ltd. . from European Biotechno...

Arix Bioscience Plc - Arix Bioscience announces first VIPE investment

Arix Bioscience Plc - Arix Bioscience announces first VIPE investment PR Newswire London, August 5 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATIO...

Aytu BioScience, Inc.: Aytu BioScience Announces Pricing of $13.2 Million Underwritten Public Offering

ENGLEWOOD, CO / ACCESSWIRE / October 5, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant ...

Aytu BioScience, Inc.: Aytu BioScience Announces Closing of $15.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

ENGLEWOOD, CO / ACCESSWIRE / October 10, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant...

Twist Bioscience Files for $86.3M IPO

Today, Twist Bioscience filed an S-1 with the U.S. Securities and Exchange Commission (SEC), announcing its intent to undergo an initial public offering. The filing shows that Twist intends to raise $...

PubMed Articles [993 Associated PubMed Articles listed on BioPortfolio]

Laboratory Safety in Parasitology Laboratory.

Working in a laboratory is very difficult and needs special attention. Laboratory workers can be exposed to numerous potential hazards including chemical, biological, physical, and radioactive. That i...

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

Optimization of laboratory procedures for intrauterine insemination: survey of methods in relation to clinical outcome.

There is a wide practice variation of used methods and outcomes in IUI in fertility laboratories. Standardization of the IUI procedure is important for reducing inconsistency among laboratories in cou...

Challenges in the analysis of novel flame retardants in indoor dust: results of the INTERFLAB 2 interlaboratory evaluation.

The Interlaboratory Study of Novel Flame Retardants (INTERFLAB 2) was conducted by 20 laboratories in 12 countries to test the precision and accuracy of the analysis of 24 "novel" flame retardants (NF...

Clinical Trials [5178 Associated Clinical Trials listed on BioPortfolio]

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Metabolic syndrome increases the risk for development of heart disease. Another condition associated with metabolic syndrome is fatty liver disease which is also referred to as nonalcoholi...

Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions

The objective of this study was the bioequivalence of a Roxane Laboratories' Pilocarpine Tablets, 5 mg, to SALAGEN® Tablets, 5 mg (MGI Pharma) under fed conditions using a single-dose, 2-...

A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions

The purpose of this study is to compare the relative bioavailability of Moexipril HCl 15mg tablets (by Paddock Laboratories, Inc.) with that of Univasc® 15mg tablets (by Schwarz Pharma) f...

Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions

The objective of this study was the bioequivalence of a Roxane Laboratories' Zaleplon Capsules, 10 mg, to Sonata ® Capsules, 10 mg (Jones Pharma) under fed conditions using a single-dose,...

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State

The objective of this study was to investigate the bioequivalence of Genpharm's clarithromycin tablets following a single, oral 500 mg (1 x 500 mg) dose compared to the Biaxin® filmtab® ...

Companies [2815 Associated Companies listed on BioPortfolio]

Advanced BioScience Laboratories, Inc. (ABL) and AlphaCore Pharma

AlphaCore Pharma

AlphaCore Pharma is an Ann Arbor-based private company focused on the development of ACP-501 as a therapy for acute coronary syndromes, and other high-risk atherosclerosis conditi...

Advanced BioScience Laboratories, Inc.

Advanced BioScience Laboratories, Inc. (ABL) and Inviragen, Inc.

Advanced BioScience Laboratories, Inc

Advanced BioScience Laboratories, Inc (ABL) has an established history of delivering quality services that advance HIV and infectious disease research for the public good. ABL is a contract research...

More Information about "Advanced BioScience Laboratories, Inc. (ABL) and AlphaCore Pharma" on BioPortfolio

We have published hundreds of Advanced BioScience Laboratories, Inc. (ABL) and AlphaCore Pharma news stories on BioPortfolio along with dozens of Advanced BioScience Laboratories, Inc. (ABL) and AlphaCore Pharma Clinical Trials and PubMed Articles about Advanced BioScience Laboratories, Inc. (ABL) and AlphaCore Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced BioScience Laboratories, Inc. (ABL) and AlphaCore Pharma Companies in our database. You can also find out about relevant Advanced BioScience Laboratories, Inc. (ABL) and AlphaCore Pharma Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record